BNP Paribas Aktienanleihe FRE 27..../ DE000PG2Z9D3 /
10/01/2025 08:30:02 | Chg.+0.05 | Bid08:55:04 | Ask08:55:04 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.09EUR | +0.05% | - Bid Size: - |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | 28.00 EUR | 27/03/2025 | Call |
GlobeNewswire
24/04/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil